Piscataqua Savings Bank’s Serina Therapeutics SER Stock Holding History

Piscataqua Savings Bank’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54	Hold	28	–	–	﹤0.01%	410
2026 Q1	$54	Hold	28	–	–	﹤0.01%	415
2025 Q4	$53	Hold	28	–	–	﹤0.01%	403
2025 Q3	$150	Hold	28	–	–	﹤0.01%	346
2025 Q2	$172	Hold	28	–	–	﹤0.01%	363
2025 Q1	$158	Hold	28	–	–	﹤0.01%	332
2024 Q4	$140	Hold	28	–	–	﹤0.01%	342
2024 Q3	$187	Hold	28	–	–	﹤0.01%	341
2024 Q2	$268	Buy	+28	New	+$276	﹤0.01%	343
2024 Q1	–	Sell	-28	Closed	-$380	–	405
2023 Q4	$380	Hold	28	–	–	﹤0.01%	344
2023 Q3	$680	Hold	28	–	–	﹤0.01%	348
2023 Q2	$890	Hold	28	–	–	﹤0.01%	340
2023 Q1	$660	Hold	28	–	–	﹤0.01%	348
2022 Q4	$550	Hold	28	–	–	﹤0.01%	339
2022 Q3	$1K	Hold	28	–	–	﹤0.01%	339
2022 Q2	$1K	Hold	28	–	–	﹤0.01%	337
2022 Q1	$1K	Hold	28	–	–	﹤0.01%	350
2021 Q4	$1K	Hold	28	–	–	﹤0.01%	338
2021 Q3	$1K	Hold	28	–	–	﹤0.01%	335
2021 Q2	$2K	Hold	28	–	–	﹤0.01%	316
2021 Q1	$2K	Buy	+28	New	+$1.96K	﹤0.01%	320

Other funds holding SER

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

AWE

Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Piscataqua Savings Bank's SER Position: Q2 2026 in Review

Piscataqua Savings Bank held its Serina Therapeutics (SER) position steady in Q2 2026 at 28 shares worth $54. The position accounts for ﹤0.01% of the portfolio, ranked #410.

Piscataqua Savings Bank first reported a position in SER in Q1 2021 and has held it in 21 quarters since. The position peaked at $2K in Q2 2021. 21 funds tracked by Wall St. Rank hold SER as of Q2 2026.

Piscataqua Savings Bank held 28 shares of Serina Therapeutics worth $54 as of Q2 2026.
Piscataqua Savings Bank left its Serina Therapeutics share count unchanged in Q2 2026.
Serina Therapeutics made up ﹤0.01% of Piscataqua Savings Bank's portfolio in Q2 2026, its #410 holding.
Piscataqua Savings Bank first reported a position in Serina Therapeutics in Q1 2021 and has held it in 21 quarters since.
Piscataqua Savings Bank's Serina Therapeutics position peaked at $2K in Q2 2021.
21 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on Piscataqua Savings Bank's 13F filing for Q2 2026, filed 9 Jul 2026.